Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis [Phase 2]
Phase 2 clinical trial evaluating MOL4239 in psoriasis completed, with results posted in December 2014.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Etanercept and Vascular Function in Psoriasis [Phase 2]
A Phase 2 study evaluating the effect of etanercept on vascular function in patients with psoriasis has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS) [Phase 3]
Phase 3 trial CADMUS reports safety and efficacy results for ustekinumab in adolescent psoriasis; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis [Phase 4]
Phase 4 trial comparing Psoralait to placebo for psoriasis has been terminated; the update does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Pulsed Dye Laser for the Psoriatic Nail
A clinical trial evaluating pulsed dye laser therapy for psoriatic nail disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Regulatory T-cells in Psoriasis Patients as Targets for Therapy
This completed clinical trial investigated regulatory T-cells as potential targets for treating psoriasis.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Cytokines and Vascular Inflammation in Psoriasis
A completed clinical trial update examining cytokines and vascular inflammation in psoriasis has been reported, with relevance to coronary a…
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject [Phase 1]
A Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of UCB5857 in healthy and psoriatic subj…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) [Phase 2]
Phase 2 trial update on apremilast (CC-10004) for moderate-to-severe plaque-type psoriasis with efficacy and safety findings completed.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis [Phase 2]
A Phase 2 parallel-group trial evaluated the efficacy and safety of Loion® compared with 10% salicylic acid in patients with scalp psoriasis…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: An Exploratory Genetic Study in Participants With Psoriasis
This document announces the completion of an exploratory genetic study in participants with psoriasis, sponsored by Janssen Research & Devel…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis [Phase 2]
Phase 2 clinical trial evaluating safety and pharmacokinetics of apremilast in recalcitrant plaque psoriasis has completed with results post…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009) [Phase 2]
A Phase 2 clinical trial evaluating Navarixin (MK-7123) for psoriasis has completed and posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of topically applied CTA018 in plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 study evaluating the efficacy and safety of CP-690,550 (tofacitinib) for moderate to severe chronic plaque psoriasis has completed. …
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis [Phase 3]
Open-label Phase 3 study evaluating the safety of multiple courses of IM alefacept in chronic plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Community Based Trial for AMEVIVE® [Phase 4]
Phase 4 community-based trial of AMEVIVE (efalizumab) for moderate to severe chronic plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Exploratory Study of Natural Killer Cells in Human Skin [NA]
Clinical trial update indicates completion of an exploratory study of natural killer cells in human skin, covering Atopic dermatitis, Contac…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy
This clinical trial update reports the clinical effectiveness and impact on health-related quality of life after 16 weeks of adalimumab ther…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Improving Psoriasis Through Health and Well-Being [NA]
This clinical trial update reports that the study investigating improvements in psoriasis through health and well-being interventions has co…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients [Phase 2]
Phase 2, topical, double-blind, randomized, placebo-controlled trial in psoriasis vulgaris has completed, sponsored by Delenex Therapeutics …
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis [Phase 2]
Phase 2 trial comparing BIRB 796 BS to placebo in moderate-to-severe plaque-type psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study [Phase 2]
A Phase 2 dose-ranging study evaluated desoximetasone topical spray at 0.05% and 0.25% for psoriasis, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments [Phase 4]
Phase 4 clinical trial update evaluating the safety and efficacy of etanercept in psoriasis patients who failed other biologic treatments. T…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis
An exploratory clinical trial assessing quality of life in patients with moderate psoriasis and moderate psoriatic arthritis, which has comp…